Výsledky vyhledávání

Cytogenetic correlation with efficacy on alemtuzumab (CAM) vs chlorambucil (CHLO) as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL)

Autor: Aleksander B. Skotnicki, Tadeusz Robak, M. Belkaci, Anna Dmoszynska, Jiří Mayer, Peter Hillmen, Y. Wang, M. Goldberg, Cynthia A. Sirard, R. Fetni

Publikováno v: Journal of Clinical Oncology. 24:6601-6601

6601 Background: CAM307, a phase III, open-label, randomized comparative trial, enrolled 297 Rai stage I-IV BCLL patients with previously untreated, progressive disease requiring treatment. Patients were randomized to treatment with CAM (n=149) vs. C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c44656fccfbed7e81b6c07d9aaaba140
https://doi.org/10.1200/jco.2006.24.18_suppl.6601

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání